28 July 2026 : Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant Recipients
Monika Górska
ABCDEF 1*, Filip Wróbel ABCDEF 2, Marta Rząsa ABCDEF 2, Ilona Kurnatowska ACDEF 1
DOI: 10.12659/AOT.952251
Ann Transplant 2026; 31:e952251
Table 4 Comparison of baseline characteristics between patients included in the multivariable regression model (complete-case analysis) and those excluded due to missing data.
| Included (n=113) | Excluded (n=14) | P value | |
|---|---|---|---|
| HS presence, n (%) | 39 (35.5) | 5 (35.7) | 0.835 |
| Male sex, n (%) | 62 (54.87) | 12 (85.71) | 0.055 |
| Age at analysis [years] | 56.07 (44.84–64.01) | 57.12±11.12 | 0.467 |
| BMI post-KTx [kg/m] | 26.05±4.17 | 25.45±2.50 | 0.886 |
| BMI pre-KTx [kg/m] | 23.98±3.70 | 24.53±2.86 | 0.589 |
| Serum creatinine [mg/dL, RR 0.55–1.02] | 1.55 (1.23–1.91) | 1.52 (1.30–1.66) | 0.635 |
| eGFR Cockroft-Gault [mL/min] | 48.3 (37.67–62.84) | 52.26±15.84 | 0.230 |
| Total cholesterol [mg/dL, RR <200] | 197.83 (173.0–214.0) | 195.98±44.93 | 0.847 |
| Low-density lipoprotein [mg/dL, RR <100] | 110.87±34.73 | 107.17±20.77 | 0.806 |
| High-density lipoprotein [mg/dL, RR >50] | 58.0 (49.0–73.5) | 60.21±18.70 | 0.896 |
| Triglycerides [mg/dL, RR <150] | 130.0 (103.0–173.0) | 150.52±82.40 | 0.790 |
| Ischemic heart disease N (%) | 25 (22.12) | 1 (7.14) | 0.337 |
| HIperuricemia N (%) | 44 (38.94) | 4 (28.57) | 0.644 |
| Values are presented as mean±SD, median (IQR), or n (%), as appropriate. HS – hepatic steatosis; KTx – kidney transplantation; RR – reference range. | |||